Business Context and Reporting Period
Company: MDxHealth SA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: November 2021
Date of Filing: November 15, 2021
Headquarters: Herstal, Belgium
This filing serves to furnish a press release issued by the Company on November 15, 2021, attached as Exhibit 99.1. The document explicitly states that the information contained in the attached press release is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Key Financial Metrics
The provided filing text does not contain specific financial data. No values are reported for revenue, profit, cash flow, margins, debt, or liquidity within this document. The filing acts solely as a conduit for the attached press release, the content of which is not included in the source text.
Material Changes
The filing text does not provide details regarding material changes versus prior periods. It references the issuance of a press release but does not summarize the specific events or financial changes discussed therein.
Guidance, Outlook, and Risks
Management Commentary: The filing includes a signature by Michael McGarrity, Chief Executive Officer, authorizing the report.
Outlook and Risks: The source text does not contain specific guidance, outlook statements, risk factors, contingencies, or descriptions of unusual items. These details would be contained within the attached Exhibit 99.1 (Press Release), which is not part of the provided text.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Press Release dated November 15, 2021) for the specific material event or announcement triggering this filing.
- Verify if the press release contains forward-looking statements or financial updates not present in this summary.
- Confirm the legal status of the information, noting that the press release content is furnished but not "filed" for liability purposes under Section 18 of the Exchange Act.